LONDON - Private equity fund Celtic Pharma Holdings II LP is taking control of Novacta Biosystems Ltd., committing to invest up to £13 million (US$21 million) in the antibiotics specialist. The money will be invested in tranches against an agreed upon schedule of milestones in three programs. (BioWorld International)